During the past decade, Jobst Vascular conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jobst Vascular" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Jobst Vascular" are "Atherosclerosis" (1 trials), "Cardiovascular Diseases" (1 trials), "Critical Limb Ischemia" (1 trials) and "Peripheral Vascular Diseases" (1 trials). Many other conditions were trialed in "Jobst Vascular" in a lesser frequency.

Most popular intervention types in "Jobst Vascular" are "Behavioral" (1 trials), "Biological" (1 trials), "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cilostazol" (1 trials), "High Dose VM202" (1 trials), "Low Dose VM202" (1 trials), "Placebo" (1 trials) and "Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jobst Vascular" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Jobst Vascular". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Jobst Vascular, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jobst Vascular, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".